We are delighted to share the great news received on Oct 11th, 2018 that Translational Lung Cancer Research (TLCR) is selected by Clarivate Analytics (former Thomson Reuters Intellectual Property and Science Business) for indexing in the following products:

Science Citation Index Expanded (also known as SciSearch®);

Journal Citation Reports/Science Edition.

TLCR is the 7th journal of AME Publishing Company included by SCIE (Figure 1), following the other six sister journals:

Figure 1Translational Lung Cancer Research with the special issue “Lung Cancer in Never Smokers” guest-edited by Prof. Adi F. Gazdar.

What’s more, TLCR is the first international journal devoted to closing the gap between “Bench and Bedside” in lung cancer and related thoracic diseases with Prof. Yilong Wu as the Honorary Editor-in-Chief, Prof. Yong Song, Prof. Caicun Zhou and Prof. Rafeal Rosell as the Editors-in-Chief, as well as the vigorous backup of a strong editorial board (Figure 2).

Particularly, we would like to extend our heartfelt gratitude to another group of experts—our Guest Editors, who have been actively involved in the forefront of scientific research and clinical practice and devoted their precious time and effort to organize the high-quality focused issues to demonstrate the cutting-edge knowledge, techniques, and discussions in their professional fields to our readers (Table 1).

Moreover, there are still our Section Editors, Reviewers and Readers worldwide that we could not express our appreciation one by one.

To TLCR, the coverage by SCIE is a milestone in its development, but also it marks an inception of a new stage with more chances and challenges forward. We look forward to the continued international teamwork to build TLCR an invaluable publication serving our scientists, doctors, patients and students, and welcome more and more excellent international peers and colleagues to join this endeavor.

Acknowledgements

None.

Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.